$7.04
8.64% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US45780L1044
Symbol
INGN

Inogen, Inc. Stock price

$7.04
+0.12 1.73% 1M
-3.33 32.11% 6M
-2.13 23.23% YTD
-4.75 40.29% 1Y
-23.10 76.64% 3Y
-24.94 77.99% 5Y
-35.56 83.47% 10Y
-8.11 53.53% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.56 8.64%

Key metrics

Basic
Market capitalization
$189.3m
Enterprise Value
$70.4m
Net debt
positive
Cash
$118.9m
Shares outstanding
26.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.6 | 0.5
EV/Sales
0.2 | 0.2
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
58.7%
Return on Equity
-20.6%
ROCE
-12.7%
ROIC
-21.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$340.0m | $360.8m
EBITDA
$-10.0m | $0.0
EBIT
$-30.9m | $-26.9m
Net Income
$-27.5m | $-28.4m
Free Cash Flow
$-21.1m
Growth (TTM | estimate)
Revenue
5.7% | 7.5%
EBITDA
80.3% | 100.0%
EBIT
55.9% | 30.6%
Net Income
71.6% | 20.8%
Free Cash Flow
18.8%
Margin (TTM | estimate)
Gross
46.1%
EBITDA
-2.9% | 0.0%
EBIT
-9.1%
Net
-8.1% | -7.9%
Free Cash Flow
-6.2%
More
EPS
$-1.1
FCF per Share
$-0.8
Short interest
3.7%
Employees
766
Rev per Employee
$440.0k
Show more

Is Inogen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Inogen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Inogen, Inc. forecast:

7x Buy
78%
1x Hold
11%
1x Sell
11%

Analyst Opinions

9 Analysts have issued a Inogen, Inc. forecast:

Buy
78%
Hold
11%
Sell
11%

Financial data from Inogen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
340 340
6% 6%
100%
- Direct Costs 183 183
4% 4%
54%
157 157
20% 20%
46%
- Selling and Administrative Expenses 169 169
5% 5%
50%
- Research and Development Expense 19 19
14% 14%
6%
-9.99 -9.99
80% 80%
-3%
- Depreciation and Amortization 21 21
8% 8%
6%
EBIT (Operating Income) EBIT -31 -31
56% 56%
-9%
Net Profit -27 -27
72% 72%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Inogen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inogen, Inc. Stock News

Neutral
Seeking Alpha
3 days ago
Inogen, Inc. (NASDAQ:INGN ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Kevin R. M. Smith - President, CEO & Director Lorna Williams - Corporate Participant Michael J.
Neutral
Business Wire
4 days ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Second Quarter 2025 Financial Results; Delivered strong top-line results; raising full year 2025 revenue expectations.
Neutral
Business Wire
26 days ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025.
More Inogen, Inc. News

Company Profile

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Head office United States
CEO Kevin Smith
Employees 766
Founded 2001
Website www.inogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today